A SINGLE mum who lives on a council estate was reduced to tears after swapping lives with a multi-millionaire. Hardworking carer Billie, 34, was given the chance to live in the eight-bedroom countr…
“I go above and beyond for anybody, I just try to do my best. I struggle a lot, really bad and I also borrow a lot of money from my mum.Speaking about the huge house, Billie said: “It’s just very overwhelming.FABULOUS BINGO:At the other end of the wealth divide, charismatic millionaire business trainer Mark, along with fiance Nikki, and his four kids spend the week in Billie’s tiny three-bed Nottingham home.
Mark decided to make his small budget stretch further by asking the local supermarket for food that was going to be thrown away. The driven businessman said: “I grew up on a council estate, now I look back there were definitely easier starts to have but at the time I didn’t know any different. A baffled but encouraged Billie said: “Reading the script throughout the workout, it made me realise, I can do this, I will do this and I won’t give up.”
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
This Devon activity holiday is ideal for single-parent families – but not entirely relaxingThis Devon activity holiday is ideal for single-parent families – but not entirely relaxing ➡️ Guests are put into a group of around 10 with whom they do all their activities, which range from zip wire and climbing to archery and orienteering
Lire la suite »
Why RPGs are best when they're built around a single cityThe next open world RPG should ditch the countryside and focus on one intricate city. And it should never make you leave.
Lire la suite »
SteffLon Don and Spice deliver like 'Clockwork'MOBO-award-winning artist SteffLon Don joins forces with Queen of Dancehall Spice to release the bold new single “Clock Work”
Lire la suite »
DCI Banks star Stephen Tompkinson to appear in court charged with grievous bodily harmDCI Banks star Stephen Tompkinson will appear in court charged with a single count of inflicting grievous bodily harm, the Crown Prosecution Service (CPS) has confirmed.
Lire la suite »
Medium- and longer-term cardiovascular effects of e-cigarettes in adults making a stop-smoking attempt: a randomized controlled trial - BMC MedicineBackground Smoking is a major risk factor for cardiovascular disease and smoking cessation reduces excess risk. E-cigarettes are popular for smoking cessation but there is little evidence on their cardiovascular health effect. Our objective was to compare the medium- and longer-term cardiovascular effects in smokers attempting to quit smoking using e-cigarettes with or without nicotine or prescription nicotine replacement therapy (NRT). Methods This was a single-center, pragmatic three-arm randomized (1:1:1) controlled trial, which recruited adult smokers (≥ 10 cigarettes/day), who were willing to attempt to stop smoking with support (n = 248). Participants were randomized to receive behavioral support with either (a) e-cigarettes with 18 mg/ml nicotine, (b) e-cigarettes without nicotine, and (c) NRT. Flow-mediated dilation (%FMD) and peak cutaneous vascular conductance (CVCmax) responses to acetylcholine (ACh) and sodium nitroprusside (SNP), mean arterial pressure (MAP), and other outcomes were recorded at baseline, 3, and 6 months after stopping smoking. Data were analyzed using generalized estimating equations (GEE). Results At 3- and 6-month follow-up, %FMD showed an improvement over baseline in all three groups (e.g., p | 0.0001 at 6 months). Similarly, ACh, SNP, and MAP improved significantly over baseline in all groups both at 3 and 6 months (e.g., ACh: p = 0.004, at 6 months). Conclusions Smokers attempting to quit experienced positive cardiovascular impact after both a 3- and 6-month period. None of the groups (i.e., nicotine-containing and nicotine-free e-cigarettes or NRT) offered superior cardiovascular benefits to the others. Trial registration ClinicalTrials.gov NCT03061253 . Registered on 17 February 2017.
Lire la suite »